Lina Karam

768 citations
14 papers · 114 indexed · h-index 6
Topics
Inflammatory Bowel Disease (6 papers)Immunodeficiency and Autoimmune Disorders (3 papers)Microscopic Colitis (3 papers)

In The Last Decade

Lina Karam

13 papers receiving 113 citations

Peers

Lina Karam
Comparison fields: 5 of 34
  • Hematology 48
  • Genetics 46
  • Genetics 37
  • Epidemiology 30
  • Surgery 20
Replace Shannon Brothers with:
Shannon Brothers New Zealand
S Corrente Italy
Gérard Couillaud France
Ravi Shah Canada
Sagir G. Ahmed Nigeria
Shereen M. Reda Egypt
D. Vassilief France
Vishal Patel United States
Christian Thorball Switzerland
Paibel Aguayo‐Hiraldo United States
Lina Karam relative to Shannon Brothers New Zealand Shannon Brothers's profile →
Citations per field
00.5×3.3×
Shannon Brothers · 1×
Citations per year

Countries citing papers authored by Lina Karam

Since Specialization
Citations

This map shows the geographic impact of Lina Karam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lina Karam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lina Karam more than expected).

Fields of papers citing papers by Lina Karam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lina Karam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lina Karam. The network helps show where Lina Karam may publish in the future.

Co-authorship network of co-authors of Lina Karam

This figure shows the co-authorship network connecting the top 25 collaborators of Lina Karam. A scholar is included among the top collaborators of Lina Karam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lina Karam. Lina Karam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 1
2 4
3 6
4
Infliximab Can Be Effective in Pediatric Patients with Ulcerative Colitis and Primary Failure of Adalimumab.
1
5 1
6 2
7 15
8 1
9 6
10 18
11
Selective lactase deficiency is common in pediatric patients undergoing upper endoscopy.
1
12 1
13 10
14 47

About Lina Karam

Lina Karam is a scholar working on Gastroenterology, Genetics and Pharmacy, having authored 14 papers that have together received 114 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (6 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Microscopic Colitis (3 papers). The work is most often cited by research in Genetics (46 citations), Hematology (48 citations) and Pharmacy (7 citations). Lina Karam has collaborated with scholars based in United States, Egypt and Lebanon. Frequent co-authors include Richárd Kellermayer, Miguel R. Abboud, Sherron M. Jackson, Paul J. Nietert, Robert D. Baker, Susan S. Baker, Virgil McKie, Joseph Laver, David Lewin and Robert C. Orth. Their work appears in journals such as Gastroenterology, Gastrointestinal Endoscopy and Inflammatory Bowel Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026